9089 Optimal duration of 1st- and 2nd-line chemotherapy (CT) for advanced non-small cell lung cancer (NSCLC)
Grossi, F., Belvedere, O., Defferrari, C., Massoni, C., Follador, A., Rijavec, E., Ceschia, T., Pronzato, P., Fasola, G., Aita, M.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71802-6
Date:
September, 2009
File:
PDF, 64 KB
english, 2009